On Monday 2 June the Officers of the APPG wrote to the Parliamentary Under-Secretary of State for Public Health and Prevention in the Department of Health and Social Care about the failure of the NHS in England to commission the use of abiraterone for use in men with non-metastatic prostate cancer.

You can read the letter below.